SE8802323L - 8alfa-acylaminoergolin, dess framstaellning samt farmaceutiska kompositioner innehaallande detsamma - Google Patents

8alfa-acylaminoergolin, dess framstaellning samt farmaceutiska kompositioner innehaallande detsamma

Info

Publication number
SE8802323L
SE8802323L SE8802323A SE8802323A SE8802323L SE 8802323 L SE8802323 L SE 8802323L SE 8802323 A SE8802323 A SE 8802323A SE 8802323 A SE8802323 A SE 8802323A SE 8802323 L SE8802323 L SE 8802323L
Authority
SE
Sweden
Prior art keywords
acylaminoergolin
8alfa
production
same
pharmaceutical compositions
Prior art date
Application number
SE8802323A
Other languages
English (en)
Other versions
SE467925B (sv
SE8802323D0 (sv
Inventor
W Haefliger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8802323D0 publication Critical patent/SE8802323D0/sv
Publication of SE8802323L publication Critical patent/SE8802323L/sv
Publication of SE467925B publication Critical patent/SE467925B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
SE8802323A 1987-06-23 1988-06-21 8alfa-acylaminoergolin, dess framstaellning samt farmaceutiska kompositioner innehaallande detsamma SE467925B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3720656 1987-06-23

Publications (3)

Publication Number Publication Date
SE8802323D0 SE8802323D0 (sv) 1988-06-21
SE8802323L true SE8802323L (sv) 1988-12-24
SE467925B SE467925B (sv) 1992-10-05

Family

ID=6330087

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8802323A SE467925B (sv) 1987-06-23 1988-06-21 8alfa-acylaminoergolin, dess framstaellning samt farmaceutiska kompositioner innehaallande detsamma

Country Status (28)

Country Link
US (1) US5075318A (sv)
JP (1) JPH0670052B2 (sv)
KR (1) KR970001527B1 (sv)
AT (1) AT395242B (sv)
AU (1) AU615657B2 (sv)
BE (1) BE1004034A3 (sv)
CA (1) CA1302404C (sv)
CH (1) CH674646A5 (sv)
CY (1) CY1752A (sv)
DK (1) DK169335B1 (sv)
ES (1) ES2010282A6 (sv)
FI (1) FI88302C (sv)
FR (1) FR2617166B1 (sv)
GB (1) GB2206115B (sv)
GR (1) GR1002318B (sv)
HK (1) HK2794A (sv)
HU (2) HU203097B (sv)
IE (1) IE60550B1 (sv)
IL (1) IL86820A (sv)
IT (1) IT1219652B (sv)
LU (1) LU87251A1 (sv)
MY (1) MY103584A (sv)
NL (1) NL8801597A (sv)
NZ (1) NZ225112A (sv)
PH (1) PH24690A (sv)
PT (1) PT87781B (sv)
SE (1) SE467925B (sv)
ZA (1) ZA884505B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL193541C (nl) * 1984-01-12 2000-01-04 Novartis Ag 8 Alfa-acylaminoergolinen, werkwijzen voor de bereiding daarvan en preparaten die ze bevatten.
JP3630888B2 (ja) * 1996-10-31 2005-03-23 株式会社ニデック レンズ搬送装置と眼鏡レンズを搬送するための眼鏡レンズ用固定カップ及びレンズ搬送方法
US8642536B2 (en) 2008-10-17 2014-02-04 Wisconsin Alumni Research Foundation Method of making biologically active alpha-beta peptides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL193541C (nl) * 1984-01-12 2000-01-04 Novartis Ag 8 Alfa-acylaminoergolinen, werkwijzen voor de bereiding daarvan en preparaten die ze bevatten.
CH666035A5 (de) * 1984-12-24 1988-06-30 Sandoz Ag 8-alpha-acylaminoergolene.

Also Published As

Publication number Publication date
JPH0670052B2 (ja) 1994-09-07
PH24690A (en) 1990-09-07
AU615657B2 (en) 1991-10-10
PT87781B (pt) 1992-10-30
US5075318A (en) 1991-12-24
DK340188D0 (da) 1988-06-21
HUT50174A (en) 1989-12-28
BE1004034A3 (fr) 1992-09-15
NL8801597A (nl) 1989-01-16
IE881867L (en) 1988-12-23
IT8848097A0 (it) 1988-06-17
AT395242B (de) 1992-10-27
GB8814615D0 (en) 1988-07-27
ZA884505B (en) 1990-02-28
IT1219652B (it) 1990-05-24
KR970001527B1 (ko) 1997-02-11
HK2794A (en) 1994-01-21
IL86820A (en) 1991-07-18
DK340188A (da) 1988-12-24
FR2617166A1 (fr) 1988-12-30
MY103584A (en) 1993-08-28
GR880100401A (el) 1989-03-08
FI88302C (sv) 1993-04-26
AU1819488A (en) 1989-01-05
HU203097B (en) 1991-05-28
KR890000479A (ko) 1989-03-14
FI883008A (fi) 1988-12-24
IL86820A0 (en) 1988-11-30
SE467925B (sv) 1992-10-05
DK169335B1 (da) 1994-10-10
ATA161788A (de) 1992-03-15
ES2010282A6 (es) 1989-11-01
GB2206115A (en) 1988-12-29
JPS6422876A (en) 1989-01-25
GR1002318B (el) 1996-05-13
HU211651A9 (en) 1995-12-28
LU87251A1 (fr) 1989-03-08
CA1302404C (en) 1992-06-02
FI88302B (fi) 1993-01-15
SE8802323D0 (sv) 1988-06-21
FI883008A0 (fi) 1988-06-22
CY1752A (en) 1994-06-03
CH674646A5 (sv) 1990-06-29
PT87781A (pt) 1989-05-31
NZ225112A (en) 1991-03-26
FR2617166B1 (fr) 1992-07-17
IE60550B1 (en) 1994-07-27
GB2206115B (en) 1991-04-03

Similar Documents

Publication Publication Date Title
DK549189D0 (da) Galanthamin-analoge samt anvendelse af disse til fremstilling af laegemidler til behandling af alzheimer's syge
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
FI911986A0 (fi) Farmaceutiska foereningar.
IT8819213A0 (it) Procedimento e dispositivo per la realizzazione di mescole di caucciu'.
HU907065D0 (en) Process for manufacturing pharmaceutical preparative of transdermal action containing 2-amino-6-(n-propyl-amino)-4,5,6,7-tetrahydro-benzothiazole
MX172600B (es) , "procedimiento para la produccion de una proteina biologicamente activa
DE3883985D1 (de) Ärztliches instrument und dessen herstellung.
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
FI972308A0 (sv) 2-substituerade 1,2,5-tiadiazolidin-3-oni-1,1-dioxider och dessa innehållande kompositioner och förfarande för deras användning
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
DK0391185T3 (da) 1,8-Naphthyridiner
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
GR3006674T3 (sv)
DK0435177T3 (da) 4-Benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-oner samt deres anvendelse som antikonvulsive midler
SE8802323L (sv) 8alfa-acylaminoergolin, dess framstaellning samt farmaceutiska kompositioner innehaallande detsamma
DE58901037D1 (de) Vorrichtung zur herstellung von klareisstuecken.
IT1224636B (it) Esteri penem 6 sostituiti come agenti antinfiammatori e antidegenerativi.
IT1170238B (it) Impiego di ibuprofene e flurbiprofene nella cura dell'erpete
IT1243088B (it) Impianto per la produzione di calzature e procedimento per l'impiego di detto impianto
IT1244562B (it) Agente per la prevenzione ed il trattamento dell'opacita' del cristallino.
DE3878988D1 (de) 1,2-di(4-isobutylphenyl)aethylen, dessen herstellung und verwendung als zwischenprodukt.
IL86752A (en) Thiophene derivatives and their preparation and their use as intermediates in the preparation of n-(2,4-dimethylthien-3-yl) -n-(1-methoxyprop-2-yl) - chloroacetamide
IT9022513A0 (it) Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.
IT8919216A0 (it) Dispositivo per la cura chirurgica dell'astigmatismo.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8802323-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8802323-9

Format of ref document f/p: F